Research
- Mr.SymBioMath (2013-2017)
FP7-PEOPLE-2012-IAPP, 7th Framework Programme
- QSTAR — Gene expression assisted compound chemistry (2011-2013)
Johnson & Johnson Pharmaceutical Research & Development, a division of Janssen Pharmaceutica N.V.
- Copy number analysis of German outbreak strain E. Coli EHEC O104:H4 (TY-2482, LB226692) by comparing it to strain K12 DH10B at Ion Torrent sequencing data
- Development of detection and feature selection methods for small copy number variations in non-oncology studies (2009-2010)
Merck Serono S.A. - Geneva
- Cell line based compound prioritization and response prediction (2009-2010)
Johnson & Johnson Pharmaceutical Research & Development, a division of Janssen Pharmaceutica N.V.
- Development of analysis and summarization techniques for Affymetrix arrays at probe level (2006-2008)
Johnson & Johnson Pharmaceutical Research & Development, a division of Janssen Pharmaceutica N.V.
- Sequential and structural analysis of avian influenza A virus genome (2006-2009)
Supported by the city of Linz